Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre

We have read with great interest the article by Kreeshan et al., which reported data on effectiveness and laboratory safety of dupilumab. We performed a retrospective study including 165 adult patients affected by moderate-to-severe atopic dermatitis (AD) and treated with dupilumab for at least 52 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Napolitano, Maddalena, Ferrillo, Maria, Patruno, Cataldo, Scalvenzi, Massimiliano, D’Andrea, Mirella, Fabbrocini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018995/
https://www.ncbi.nlm.nih.gov/pubmed/33712985
http://dx.doi.org/10.1007/s13555-021-00505-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018995/
https://www.ncbi.nlm.nih.gov/pubmed/33712985
http://dx.doi.org/10.1007/s13555-021-00505-z

Ejemplares similares